ArticleInflammation2025
AR Deficiency Protects Against Sepsis-Induced Acute Lung Injury by Inhibiting Macrophage M1 Polarization and Inflammatory Cytokine Secretion.
Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- MiR-24-3p delivered by adipose derived stem cells exosomes alleviate macrophage pyroptosis via NLRP3/Caspase1/GSDMD in sepsis ALI.Stem cell research & therapy · 2025Article
- Identification of anoikis-related genes classification patterns and immune infiltration characterization in chronic rhinosinusitis with nasal polyps based on machine learning.Frontiers in molecular biosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Acute lung injury (ALI) constitutes a major public health concern, with sepsis contributing to up to 50% of ALI cases in the ICU. Androgen receptor (AR) plays a crucial role in immunoregulation. Our study aimed to explore the role of AR and the underlying regulatory mechanisms of AR signaling in septic ALI. We assessed the role of AR in a septic ALI model by manipulating AR expression through orchiectomy, AR knockout, and enzalutamide treatment. Lung injury was evaluated by HE staining and measuring pulmonary vascular leakage. Inflammatory cell infiltration and inflammatory mediator levels were assessed through Immunofluorescence staining and western blot. Additionally, Weighted Gene Co-expression Network Analysis (WGCNA), lentiviral vector, chromatin immunoprecipitation and co-immunoprecipitation were used to elucidate the molecular mechanisms by which AR regulates the secretion of inflammatory cytokines in alveolar macrophages. Male mice exhibited more severe lung injury than female mice in sepsis-induced lung injury. Orchiectomy, AR knockout and enzalutamide treatment suppressed AR activity and significantly alleviated lung injury. AR promotes Fkbp5 expression and NF-κB signaling pathway, thereby enhancing the expression of iNOS and IL-6 in macrophages. Moreover, AR transcription in alveolar macrophages is regulated by hypoxia-inducible factor 1α (HIF1α) signaling. Our study elucidated that inhibiting AR decreases the secretion of inflammatory cytokines in alveolar macrophages and mitigates septic ALI, providing a novel therapeutic approach for septic ALI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.